- Merck Says Covid Drug Cut Hospitalization, Deaths by Half (Bloomberg)
- Evergrande bonds are being scooped up by bargain-hunting funds on bets China can ward off a messy collapse, reports say (Business Insider)
- Exxon Sees up to $1.5 Billion Third-Quarter Earnings Boost From Gas and Oil Rally (Barron’s)
- Merck to seek emergency US approval of oral COVID treatment (New York Post)
- Try These Dividend Stocks for Some Inflation Protection (Barron’s)
- Will the Supply-Chain Crisis Wreck the Holidays? What Investors—and Shoppers—Need to Know. (Barron’s)
- NIO, Li Auto Report Great Deliveries. What Chip Shortage? (Barron’s)
- Cigna, Humana, UnitedHealth to expand into new Medicare Advantage markets in 2022 (marketwatch)
- Coty to sell 9% stake in Wella to majority owner KKR (Reuters)
- 4 reasons why Dollar Tree is raising prices above $1 but below $3 and why the stock has 30% upside ahead, according to JPMorgan (Business Insider)